½ÃÀ庸°í¼­
»óǰÄÚµå
1747527

À§³» dz¼± ½ÃÀå : Á¦Ç° À¯Çüº°, ÃæÀüÀ纰, ÃÖÁ¾ »ç¿ëÀÚº°, À¯Åë ä³Îº°, Áö¿ªº°

Intragastric Balloon Market, By Product Type, By Filling Material, By End User, By Distribution Channel, By Region

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

À§³» dz¼± ½ÃÀåÀº 2025³â¿¡´Â 1¾ï 7,570¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â¿¡´Â 3¾ï 3,590¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â¿¡ °ÉÃÄ 9.7%ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â ½ÃÀå ±Ô¸ð(2025³â) 1¾ï 7,570¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 9.70% °¡Ä¡ ¿¹Ãø(2032³â) 3¾ï 3,590¸¸ ´Þ·¯

À§³» dz¼±Àº üÁß °¨·® °ü¸® ºÐ¾ß¿¡¼­ Å« ÁÖ¸ñÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ ºñ¿Ü°úÀû ¼ö¼ú¿¡¼­´Â À§¿¡ dz¼±À» »ðÀÔÇÏ¿© °ø°£À» È®º¸Çϰí, Æ÷¸¸°¨À» ÃËÁøÇÏ´Â °ÍÀ¸·Î üÁß °¨¼Ò·Î À̾îÁý´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°èÀÇ À§³» dz¼± ½ÃÀåÀº ÇâÈÄ ¼ö³â°£ ´ëÆøÀûÀÎ ¼ºÀåÀÌ ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

±×·¯³ª, ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀεµ ÀÖ½À´Ï´Ù.dz¼±ÀÇ ¼öÃàÀ̳ª À̵¿, À§±Ë¾ç, À§Àå Æó»öµîÀÇ À¯ÇØ »ç°ÇÀÌ º¸°íµÇ°í ÀÖ´Â °æ¿ìµµ ÀÖ¾î, ÀáÀçÀûÀΠȯÀÚ°¡ ÀÌ ¼ö¼úÀ» ¼±ÅÃÇÏ´Â °ÍÀ» ÁÖÀúÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À§³» dz¼± Ä¡·áÀÇ °í¾×ÀÇ ºñ¿ë°ú, ÀϺΠÁö¿ª¿¡¼­´Â »óȯ

ÀÌ·¯ÇÑ ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀο¡µµ ºÒ±¸ÇÏ°í ½ÃÀå¿¡´Â ¼ºÀå ±âȸ°¡ ¸î °¡Áö Á¸ÀçÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 3¿ù ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üÀÎ ÇÁ¸®½ºÆ¾ Äɾî´Â ÀÇ·á ±â±â ȸ»çÀÎ ¾Ë·ç¸®¿Â Å×Å©³î·ÎÁö½º¿Í Çù·ÂÇÏ¿© üÁß °¨·® ¹× ºñ¸¸ °ü¸®¸¦ À§ÇÑ À§³» dz¼±À̶ó´Â Á¾ÇÕ ¼Ö·ç¼ÇÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ÇÁ·Î±×·¥ÀÇ ÁÖ¿ä ¸ñÀûÀº 16ÁÖ °£ÀÇ Ä¡·á ±â°£ µ¿¾È ȯÀÚÀÇ Ã¼ÁßÀ» ¾à 10-15% °¨¼Ò½ÃŰ´Â °ÍÀÔ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ½ÃÀå ±Ô¸ð¿Í ¼ºÀå·ü : º» º¸°í¼­¿¡¼­´Â 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© 2025-2032³âÀÇ ¿¹Ãø±â°£¿¡¼­ ÃøÁ¤ÇÑ ½ÃÀå ±Ô¸ð¸¦ »ó¼¼ÇÏ°Ô ºÐ¼®Çß½À´Ï´Ù.
  • ¼öÀÍ ±âȸ ¹× ÅõÀÚ Á¦¾È : º» Á¶»ç¿¡¼­´Â ´Ù¾çÇÑ ½ÃÀå ºÎ¹®ÀÇ ÀáÀçÀû ¼öÀÍ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí ÀÌÇØ °ü°èÀÚ¿¡°Ô ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀ» Á¦½ÃÇÕ´Ï´Ù.
  • ½ÃÀå ÀλçÀÌÆ® : ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ, ½ÃÀå ±âȸ, ½ÃÀå µ¿Çâ, ½ÅÁ¦Ç° ¹ß¸Å, Áö¿ª Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ ÁÖ¿ä ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ : ¼¼°èÀÇ À§³» dz¼± ½ÃÀå¿¡¼­ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» °ÔÀçÇÏ°í ±â¾÷ ¹è°æ, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀ» ¼Ò°³Çß½À´Ï´Ù.
  • ÁÖ¿ä ±â¾÷ : Allurion Technologies, Allergan(Abbott Àμö), Apollo Endosurgery, Reshape Medical, Spatz FGIA, Endalis, Silimed, Medsil, Districlass medical µîÀÇ À¯¸í ±â¾÷ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.
  • ÀÇ»ç°áÁ¤ Áö¿ø : º» º¸°í¼­ÀÇ ÀλçÀÌÆ®¿¡ ÀÇÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ³ª °æ¿µÁøÀº Á¦Ç° ¹ß¸Å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ °üÇØ¼­, Á¤º¸¿¡ ±Ù°ÅÇÑ ÀÇ»ç °áÁ¤À» ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ¿¡ ´ëÇÑ ¹è·Á : º» º¸°í¼­´Â À§³» dz¼± ½ÃÀåÀÇ ÅõÀÚÀÚ, °ø±ÞÀÚ, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ¾Ö³Î¸®½ºÆ®¸¦ ´ë»óÀ¸·Î Çϰí ÀÖ¾î ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¼­Æ÷Æ®ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° Ãâ½Ã/½ÂÀÎ
  • PEST ºÐ¼®
  • PORTER's ºÐ¼®
  • ÇÕº´°ú Àμö ½Ã³ª¸®¿À

Á¦4Àå ¼¼°èÀÇ À§³» dz¼± ½ÃÀå : Á¦Ç° À¯Çüº°(2020-2032³â)

  • ´ÜÀÏ Ç³¼±
  • ÀÌÁß Ç³¼±
  • »ïÁß Ç³¼±

Á¦5Àå ¼¼°èÀÇ À§³» dz¼± ½ÃÀå : ÃæÀüÀ纰(2020-2032³â)

  • ½Ä¿°¼ö ÃæÀü
  • °¡½º ÃæÀü

Á¦6Àå ¼¼°èÀÇ À§³» dz¼± ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2020-2032³â)

  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð

Á¦7Àå ¼¼°èÀÇ À§³» dz¼± ½ÃÀå : À¯Åë ä³Îº°(2020-2032³â)

  • ¿Â¶óÀÎ ¾à±¹
  • ¼Ò¸Å ¾à±¹
  • º´¿ø ¾à±¹

Á¦8Àå ¼¼°èÀÇ À§³» dz¼± ½ÃÀå : Áö¿ªº°(2020-2032³â)

  • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
  • À¯·´
      • ¿µ±¹
      • µ¶ÀÏ
      • ÀÌÅ»¸®¾Æ
      • ÇÁ¶û½º
      • ½ºÆäÀÎ
      • ·¯½Ã¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • Àεµ
      • ÀϺ»
      • ASEAN
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
      • ºê¶óÁú
      • ¸ß½ÃÄÚ
      • ¾Æ¸£ÇîÆ¼³ª
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
      • GCC
      • À̽º¶ó¿¤
      • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
      • ºÏ¾ÆÇÁ¸®Ä«
      • Áß¾Ó ¾ÆÇÁ¸®Ä«
      • ³²¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • Allurion Technologies
  • Allergan(Acquired by Abbott)
  • Apollo Endosurgery
  • Reshape Medical
  • Spatz FGIA
  • Endalis
  • Silimed
  • Medsil
  • Districlass Medical

Á¦10Àå ¼½¼Ç

  • Á¶»ç¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
KTH 25.06.23

Intragastric Balloon Market is estimated to be valued at USD 175.7 Mn in 2025 and is expected to reach USD 335.9 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 9.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 175.7 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.70% 2032 Value Projection: USD 335.9 Mn

Intragastric balloons have gained significant attention in the field of weight loss management. This non-surgical procedure involves the insertion of a balloon into the stomach, which occupies space and promotes satiety, leading to weight loss. The intragastric balloon serves as a temporary solution for individuals looking to shed excess pounds without undergoing invasive surgeries such as gastric bypass or sleeve gastrectomy.

Market Dynamics

The global intragastric balloon market is expected to experience substantial growth in the coming years. Several factors contribute to this growth including the rising prevalence of obesity worldwide and the increasing demand for minimally invasive weight loss procedures. Additionally, the growing awareness about the long-term health risks associated with obesity is driving individuals to seek effective weight management solutions.

However, there are certain restraints that could impede the market growth. Adverse events, such as balloon deflation or migration, gastric ulcers, and gastrointestinal obstructions, have been reported in some cases, which might deter potential patients from opting for this procedure. Moreover, the high cost of intragastric balloon treatment and the lack of reimbursement options in some regions pose challenges for market penetration.

Despite these restraints, the market presents several opportunities for growth. Technological advancements in balloon design and materials, such as the introduction of adjustable balloons and self-sealing valves, offer improved patient outcomes and enhanced safety profiles. Moreover, the growing adoption of intragastric balloons in emerging markets provides significant opportunities for market expansion. For instance, in March 2023, Pristyn Care, a healthcare provider, collaborated with Allurion Technologies, a medical device company to introduce a comprehensive solution which is intragastric balloon for weight loss and obesity management. This innovative program introduces the world's first ingestible gastric balloon, eliminating the need for surgery, endoscopy, or anesthesia. The primary goal of the program is to assist patients in shedding approximately 10 to 15% of their body weight over a 16-week treatment period. As a result of the growing popularity of minimally invasive treatments and supportive initiatives, significant market expansion is anticipated.

Key Features of the Study

  • Market Size and Growth Rate: The report provides an in-depth analysis of the market size, measured in (US$ million), and the Compound Annual Growth Rate (CAGR) for the forecast period of 2025-2032, considering 2024 serving as the base year
  • Revenue Opportunities and Investment Proposition: The study identifies potential revenue growth opportunities across different market segments and presents attractive investment propositions for stakeholders
  • Market Insights: It offers key insights into market drivers, restraints, opportunities, market trends, new product launches, regional outlook, and competitive strategies adopted by key players
  • Company Profiles: The report profiles key players in the global intragastric balloon market, highlighting their company background, product portfolio, key highlights, financial performance, and strategies
  • Key Players: The study includes prominent companies such as Allurion Technologies, Allergan (Acquired by Abbott), Apollo Endosurgery, Reshape Medical, Spatz FGIA, Endalis, Silimed, Medsil, and Districlass medical
  • Decision-making Support: Insights from this report enable marketers and management authorities to make informed decisions regarding product launches, market expansion, and marketing tactics
  • Stakeholder Considerations: The report caters to investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts in the intragastric balloon market, supporting decision-making through various strategy matrices

Intragastric Balloon Market Segmentation

  • By Product Type
    • Single Balloon
    • Dual Balloon
    • Triple Balloon
  • By Filling Material
    • Saline Filled
    • Gas Filled
  • By End User
    • Hospitals
    • Ambulatory Surgical Centers
    • Clinics
  • By Distribution Channel
    • Online Pharmacies
    • Retail Pharmacies
    • Hospitals Pharmacies
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Intragastric Balloon Market
    • Allurion Technologies
    • Allergan (Acquired by Abbott)
    • Apollo Endosurgery
    • Reshape Medical
    • Spatz FGIA
    • Endalis
    • Silimed
    • Medsil
    • Districlass medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Intragastric Balloon Market, By Product Type
    • Intragastric Balloon Market, By Filling Material
    • Intragastric Balloon Market, By End User
    • Intragastric Balloon Market, By Distribution Channel
    • Intragastric Balloon Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
      • Rising prevalence of obesity
    • Restraints
      • Adverse events and complications
    • Opportunities
      • Huge untapped patient population in developing countries
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Intragastric Balloon Market, By Product Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Single Balloon
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Dual Balloon
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Triple Balloon
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

5. Intragastric Balloon Market, By Filling Material, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Saline Filled
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Gas Filled
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

6. Intragastric Balloon Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

7. Intragastric Balloon Market, By Distribution Channel, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Hospitals Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

8. Intragastric Balloon Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Filling Material, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Filling Material, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Filling Material, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Filling Material, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Filling Material, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Filling Material, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Allurion Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Allergan (Acquired by Abbott)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Apollo Endosurgery
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Reshape Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Spatz FGIA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Endalis
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Silimed
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medsil
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Districlass Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦